In the model, we assumed that the predictors were PON1 and lipoproteins (HDL and LDL), the mediating variables were spirometry (FEV1) and heart rate variability (HRV), and the criterion was the functionality of ALS patients. The gene discussed is PON1; the disease is amyotrophic lateral sclerosis.